NEUPNasdaq United States
Market cap
$20.645 M
$3.82 -2.05%
Close of 7 Aug 2026
Revenue
$15.6M
#3078 by revenue
Earnings
-$400.0K
Loss-making
Shares outstanding
5,404,551
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Neuphoria Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.